報價延遲最少15分鐘:2025/06/02 18:36 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.31 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.13/--
|
|
企業價值
589.61M
|
| 資產負債 |
|
每股賬面淨值
3.93
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/06/02 18:36 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. |